The Financial Express on MSN1d
Complan grows up, Zydus takes kids’ health drink into adult’s wellness marketDiscover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging ...
Completion of the transaction to be followed by mandatory simplified tender offer Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical ...
Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...
Hosted on MSN1mon
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment"FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Zydus Lifesciences has introduced ANVIMO, a breakthrough medication for preventing Cytomegalovirus (CMV) infection in haematopoietic stem cell and kidney transplant patients. The drug, containing ...
Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...
Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback